Single or Repeat Dose of G03-52-01 in Adult Subjects

NCT05348993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

622

Enrollment

FED

Sponsor class

Conditions

Healthy
Botulinum Toxin

Interventions

DRUG: G03-52-01
DRUG: Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]